Masso Torrence Wealth Management Inc. Has $2.43 Million Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Masso Torrence Wealth Management Inc. lifted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 27,017 shares of the exchange traded fund’s stock after acquiring an additional 796 shares during the period. SPDR S&P Biotech ETF accounts for about 1.3% of Masso Torrence Wealth Management Inc.’s portfolio, making the stock its 20th largest position. Masso Torrence Wealth Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $2,433,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of XBI. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of SPDR S&P Biotech ETF by 198.6% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after purchasing an additional 6,138,000 shares during the period. Clal Insurance Enterprises Holdings Ltd bought a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at about $141,284,000. Mirae Asset Securities USA Inc. boosted its holdings in SPDR S&P Biotech ETF by 50.0% in the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after acquiring an additional 300,000 shares in the last quarter. Assetmark Inc. grew its stake in SPDR S&P Biotech ETF by 72,653.0% in the third quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after acquiring an additional 588,489 shares during the period. Finally, Whittier Trust Co. increased its holdings in shares of SPDR S&P Biotech ETF by 3.3% during the third quarter. Whittier Trust Co. now owns 311,027 shares of the exchange traded fund’s stock valued at $30,729,000 after acquiring an additional 9,976 shares in the last quarter.

SPDR S&P Biotech ETF Stock Up 0.2 %

Shares of NYSEARCA:XBI opened at $93.34 on Wednesday. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The stock’s 50 day moving average is $93.35 and its 200-day moving average is $96.83. The firm has a market capitalization of $7.11 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.